Illumina (ILMN) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.44
- Estimate
- $1.36
- Surprise
- +6.1%
- Revenue (period 2026-09-27)
- $1.13B
- Score at report (before → after)
- 4.5 → 4.7/10
Revenue source: xbrl.
How the report landed
Illumina (ILMN) beat the $1.36 estimate with adjusted EPS of $1.44 — a clear 6.1% upside surprise. TrendMatrix's engine moved from Hold (4.5/10) to Sell at 4.7/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates ILMN Hold at 5.8/10.
4 of the last 4 quarters beat the estimate; this quarter's +6.1% surprise compares with a +7.9% four-quarter average. Next scheduled report: 2027-02-04.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.8 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Product: sequencing revenue (92.0%)
- Concentration risk — Supplier: single-source suppliers
- Momentum score 4.1/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $200.66
- Price target
- $235.31
- Stop
- $190.71
- Upside to target
- +17.3%
- Reward-to-risk
- 1.3:1
At 36.1× trailing and 34.0× forward earnings, consensus estimates imply little change in earnings power.
Model outputs from TrendMatrix’s engine as of 2026-11-19 — shown for context, not personalized investment advice.
ILMN at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Diagnostics & Research
- Market cap
- $31.75B
- P/E (fwd)
- 34.0
- P/E (ttm)
- 36.1
- 52-week range
- $112.65–$309.35
- Off 52-week high
- 35.1%
- RSI (14)
- 34
- Volume vs avg
- 0.76×
- Score today
- 5.8/10